The data base provided by Kline-Fath et al which contain a look up table including the previously estimated gestational age and the measured indices was used as the base of estimations in the software. The Caretta Software, GUI Design Studio was used for programming. This software let the user to generate interactive prototypes without writing a code. Results: The GA will be estimated just in two steps using this software. At the first page the user can select the index of interest which was measured on the MRI image. Another page will open and the measured value should be entered and simply the estimated gestational age will be appeared on the page. Conclusions: This software can be very helpful in reducing the GA estimation time and besides it partially eliminates the human error.
Objectives: Fetal growth restriction (FGR) is associated with increased fetal and neonatal mortality and morbidity, which can lead to immediate perinatal adverse events. However, effective options to predict FGR still lack of consensus, and need more studies to follow. We aim at achieving the efficacy of the evaluation of ultrasound fetal growth measurements and Doppler parameters to predict FGR. Methods: Case-control study within a prospective cohort of singleton pregnancies for third trimester was enrolled. Women accepted ultrasound examination every 4 weeks from 28 to 41 weeks. Growth measurements including BPD, HC, AC and FL were recorded for this study. Doppler parameters, such as UA-PI, MCA-PI and MCA-PSVmom were analysed. Meanwhile, we calculated each measure Zscore with INTERGROWTH-21st fetal growth standards form. We set up predictive models within fetal growth values Zscore to predict FGR and adverse perinatal outcome(APO). Control group(BW≥10th%) and FGR group (BW<10th%) were settled as two groups. APO was defined as the presence of non-reassuring fetal status requiring emergent Caesarean, 5-minute Apgar score<7', neonatal metabolic acidosis at birth or stillbirth. Results: A total of 834 patients fulfilling the inclusion criteria were included. After the exclusion of 143 lost cases, 565 cases of Control group and 126 cases of FGR group were obtained. Among them, 33 neonates have an adverse perinatal outcome. We established a model with the measures Zscore predict FGR and APO. Its accuracy was higher than INTERGROWTH-21st EFW Zscore. However, the performance of the model was similar to that obtained by measures Zscore combined with Doppler indices was significant contributors to the prediction of FGR and APO. Conclusions: The use of measures Z-score provides a good prediction for FGR and APO in the general population. Meanwhile, UA-PI and MCA-PI combined with measures predict APO of some significance. woman was randomly selected to include 1,000 events. Exclusion criteria: maternal or fetal morbidity, or with estimated fetal weight above the 90 or below the 10 percentile. A mean and standard deviation for the renal artery (RA) peak systolic velocity (RAPSV), RA resistance index (RARI), RA pulsatility index (RAPI) and RA systolic diastolic ratio (RASDR) were derived for each week of gestation from 20 through 40 weeks. Second-degree polynomials for all regressions. The log transformation provided the best normalisation as determined by visual assessment of the values. Results: Graphs of the values for all of the renal artery Doppler indices and their Z-scores were created for the RAPI (figure 1), and for the RAPSV, RASDR, and the RARI (Supplementary data 1-3) . Conclusions: A series of reference values for renal artery Doppler assessment has been created. The references were derived from a population of healthy women between the 20 and 40 week of gestation. The clinical utility of these measurements need to be determined within specific clinical situations and may help understand peripheral changes in the fetal circulation that occur during pregnancy complications or after exposure to medications.
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